Results 61 to 70 of about 23,691 (214)

Sentinel lymph node biopsy in periocular merkel cell carcinoma: a case report

open access: yesBMC Research Notes, 2017
Background The National Comprehensive Cancer Network guidelines for Merkel cell carcinoma recommend performance of the sentinel lymph node biopsy in all patients with clinically negative nodal disease for staging and treatment.
Dan C. Filitis   +3 more
doaj   +1 more source

Timing Matters: A Meta‐Analysis of BREAST‐Q Administration in Tissue‐Expander and Implant‐Based Breast Reconstruction

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background BREAST‐Q is the most widely used patient‐reported outcome measure following breast reconstruction, yet no consensus exists on optimal timing or duration of administration. We analyzed BREAST‐Q follow‐up after implant‐based reconstruction, comparing direct‐to‐implant (DTI) and two‐stage tissue expander (TE), to determine how outcomes
Emanuella M. Brito   +8 more
wiley   +1 more source

Sentinel Lymph Node Biopsy in Eyelid Malignancy - A Brief Update

open access: yesDelhi Journal of Ophthalmology, 2020
Sentinel lymph node biopsy detects metastasis in the initial stages before the regional spread becomes clinically detectable and aids in the staging of the tumor.
Neelam Pushker, Gautam Lokdarshi
doaj   +1 more source

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)

open access: yesBMC Cancer, 2017
Background Studies showed that axillary lymph node dissection can be safely omitted in presence of positive sentinel lymph node(s) in breast cancer patients treated with breast conserving therapy.
L. M. van Roozendaal   +15 more
doaj   +1 more source

Nanomedicine applications in lymphoma: Advancing precision diagnostics, targeted therapeutics, and prospective developments

open access: yesVIEW, EarlyView.
Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf   +5 more
wiley   +1 more source

A Multicenter Non‐Inferiority Randomized Controlled Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Conventional Dual Tracer Versus Superparamagnetic Iron Oxide

open access: yesWorld Journal of Surgery, EarlyView.
The gold standard for detecting sentinel lymph node (SLN) in early breast cancer is combined use of radioisotope and blue dye. A newer agent, superparamagnetic iron oxide (SPIO), was developed to address the challenges faced with the traditional method.
Chiu Hoi Woon Tiffany   +5 more
wiley   +1 more source

Sentinel lymph node biopsy in penile cancer: a comparative study using modified inguinal dissection

open access: yesInternational Brazilian Journal of Urology, 2008
INTRODUCTION: In the case of clinically negative inguinal regions in penile cancer, the treatments proposed might vary from careful observation to radical dissection for all patients. We evaluated the effectiveness of the sentinel lymph node biopsy using
Ubirajara Ferreira   +4 more
doaj   +1 more source

Recurrence Patterns and Prognostic Factors in Sentinel Lymph Node‐Negative Melanoma in a Taiwanese Cohort With Predominant Acral Melanoma

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Cutaneous melanoma in Asian populations is characterized by a predominance of acral melanoma and distinct clinicopathologic features. Although sentinel lymph node biopsy (SLNB) is widely used for staging, a subset of SLN‐negative patients still develop recurrence, and evidence regarding recurrence patterns and prognostic factors in this group ...
Chih‐Yuan Chang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy